Erick Lucera - Sep 18, 2023 Form 4 Insider Report for Bone Biologics Corp (BBLG)

Role
Director
Signature
/s/ Erick Lucera
Stock symbol
BBLG
Transactions as of
Sep 18, 2023
Transactions value $
$0
Form type
4
Date filed
9/20/2023, 02:54 PM
Previous filing
May 18, 2023
Next filing
Mar 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBLG Non-Employee Stock Option Award $0 +85.8K $0.00 85.8K Sep 18, 2023 Common Stock 85.8K $0.64 Direct F1
holding BBLG Non-Employee Stock Option 1.23K Sep 18, 2023 Common Stock 1.23K $48.41 Direct F2
holding BBLG Non-Employee Stock Option 291 Sep 18, 2023 Common Stock 291 $105.60 Direct F2
holding BBLG Non-Employee Stock Option 99 Sep 18, 2023 Common Stock 99 $157.50 Direct F2
holding BBLG Non-Employee Stock Option 677 Sep 18, 2023 Common Stock 667 $157.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests quarterly through the date of the next annual meeting of the stockholders of the Company following the Grant.
F2 This option is fully vested as of the date of this report.